Cargando…
A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma
Rituximab is a chimeric human-mouse anti-CD20 monoclonal antibody, which is used in the treatment of both B-cell lymphomas and rheumatic diseases. We describe a case of a previously healthy 57-year-old man developing arthritis while being treated with rituximab-CHOP chemotherapy (R-CHOP) for a non-H...
Autores principales: | Swaneveld, F. H., van Vugt, R. M., de Boer, J. P., Dijkmans, B. A. C., Lems, W. F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262146/ https://www.ncbi.nlm.nih.gov/pubmed/17660934 http://dx.doi.org/10.1007/s10067-007-0704-0 |
Ejemplares similares
-
Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice
por: Bascuas, Thais, et al.
Publicado: (2018) -
CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi
por: Gopal, Satish, et al.
Publicado: (2016) -
Myiasis in an 89-Year-Old Man with Non-Hodgkin Lymphoma
por: Alizadeh, Afshin Mohammad, et al.
Publicado: (2013) -
“Crack lung and heart” presenting after chemotherapy in a 65-year-old man with non-Hodgkin lymphoma
por: Alvarez, G.G., et al.
Publicado: (2008) -
Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy
por: Kim, Tark, et al.
Publicado: (2012)